CELC
CELC
NASDAQ · Biotechnology

Celcuity Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$90.21
+0.28 (+0.31%)
As of Jun 23, 9:53 PM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target -71.7% upside
Low Target $16.07
Average Target $25.56
High Target $38.64
Current Price $90.21
Current
$90.21
Target
$25.56
$16.07 $25.56 avg $38.64
Scenario Analysis
Bear Case
$16.07
-82.2%
Low target
Base Case
$25.56
-71.7%
Avg target
Bull Case
$38.64
+-57.2%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$151.02
-40.3% from high
52-Week Low
$11.28
+700.1% from low
50-Day SMA
$105.59
-14.6% vs SMA
200-Day SMA
$59.11
+52.6% vs SMA
RSI (14)
39.6
Neutral
Target vs 52W High
$25.56
-83.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%